DIBIASE MARY (Chief Operating Officer) sold 1.2% of their position (3.68K shares) of X4 PHARMACEUTICALS, INC on the open market
Open‑market sale worth $3.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/12/2024ACC: 0001628280-24-004288
Officer· Chief Operating Officer
Since Sep 2021
-3.68K
Net shares
Net seller
$3.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.68K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.68K
Price / share
$1.01
Trade value
$3.71K
% of position
1.2%
2/12/2024
310.84K→307.16K
Total
Net shares
−3.68K
Net value
-$3.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/12/2024 | S · Sale | −3.68K | $1.01 | $3.71K | 1.2% | 310.84K | 307.16K |
| Total | −3.68K | -$3.71K | ||||||
Derivative Transactions0
No derivative transactions reported